Snyder’s-Lance, Inc. Reports Third Quarter 2017 Financial Results
Nov 07, 2017 13:02 pm UTC| Business
Total net revenue from continuing operations increased 3.7%; core branded growth of 4.9%GAAP net loss per share of $0.60 from continuing operations including non-recurring, non-cash expense of $0.87 per shareEPS from...
Nov 07, 2017 13:02 pm UTC| Business
SILICON SLOPES, Utah, Nov. 07, 2017 -- Lucidchart, a visual productivity platform that helps anyone understand and share complex ideas, information and processes, today unveiled Lucidchart for Quip, available on the...
Nov 07, 2017 13:02 pm UTC| Business
CAMBRIDGE, Mass., Nov. 07, 2017 -- Jounce Therapeutics, Inc. (NASDAQ:JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers for patient...
Nov 07, 2017 13:02 pm UTC| Business
PITTSBURGH, Pa., Nov. 07, 2017 -- Krystal Biotech, Inc. (Nasdaq:KRYS), a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from dermatological diseases, today...
Willis Lease Finance Reports Third Quarter Pretax Profit Grew 27% to $8.3 Million
Nov 07, 2017 13:02 pm UTC| Business
NOVATO, Calif., Nov. 07, 2017 -- Willis Lease Finance Corporation (NASDAQ:WLFC) today reported that pretax income grew 27% to $8.3 million in the third quarter of 2017, compared to $6.5 million in the third quarter of...
Nov 07, 2017 13:02 pm UTC| Business
ZUG, Switzerland and CAMBRIDGE, Mass., Nov. 07, 2017 -- CRISPR Therapeutics (NASDAQ:CRSP), a genome editing company focused on creating transformative medicine for serious diseases, today announced that the Company will...
Nov 07, 2017 13:02 pm UTC| Business
ANN ARBOR, Mich., Nov. 07, 2017 -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), the Lipid Management Company focused on developing and commercializing convenient, complementary, cost-effective, once-daily, oral therapies...